NCT06954116
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Clinical trial condition
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Explore clinical trials studying Resectable Hepatocellular Carcinoma With High Risk of Recurrence. Study availability and eligibility vary by location and protocol.
3 public trials
3 recruiting studies
Resectable Hepatocellular Carcinoma With High Risk of Recurrence trial results
NCT07239245
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Science Beijing, Beijing Municipality, China
- Henan Cancer Hospital Zhengzhou, Henan, China
- The First Hospital of China Medical University Shenyang, Liaoning, China
- Shanxi Cancer Hospital Taiyuan, Shanxi, China
Recruiting
The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)
NCT07064681
- Conditions
- Resectable Hepatocellular Carcinoma With High Risk of Recurrence
- Locations
-
- The first affiliated hospital of SYSU Guangzhou, Guangdong, China